Abstract

Pre-eclampsia, the obstetric disorder characterized by hypertension and proteinuria prevails all over the world and presents as a pressing peril for fetal and maternal lives. Though inflammation, increased levels of TXA2, ischemic placenta, dysfunction of endothelium are discerned, the exact pathophysiology yet remains a mystery. The absolute treatment is still to be discovered, however its prevention by low dose aspirin presents as a relieving factor for Pre-eclampsia. In this review, with the pathophysiology, diagnosis, risk factors, prevention and various trials done, low dose aspirin stands as the recommended choice. The various outcomes of research include controlled blood pressure, decreased proteinuria, pregnancy complications, miscarriages and growth restrictions in foetus.